NetworkNewsBreaks – Abeona Therapeutics Inc. (NASDAQ: ABEO) Featured in Mizuho Securities Research Report
Abeona Therapeutics Inc. (NASDAQ: ABEO) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Abeona reported 1Q20 results yesterday. 1Q20 EPS was $(0.52) vs. Bloomberg consensus of $(0.24). We do not see earnings as the most meaningful driver of ABEO at this stage. Covid-19 has had some impact on operations but we believe the situation is manageable. Enrollment in the pivotal EB-101 trial could be complete by YE20, depending when patient dosing can resume at the Stanford site. In the MPS III programs, we expect new biomarker updates at ASGCT. We maintain…